Author

O. A. Garden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Assay:clinical cohort / trial· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

B. Bilanges· 1 shared B. Glanemann· 1 shared B. Vanhaesebroeck· 1 shared C. J. Courreges· 1 shared C. Scudamore· 1 shared D. Sansom· 1 shared E. C. Davenport· 1 shared E. Rebollo-Gomez· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. Bilanges

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development

C. J. Courreges, E. C. Davenport, B. Bilanges, E. Rebollo-Gomez, J. Hukelmann, P. Schoenfelder, J. R. Edgar, D. Sansom, C. Scudamore, R. Roychoudhuri, O. A. Garden, B. Vanhaesebroeck, K. Okkenhaug

This study shows that VPS34 deficiency in regulatory T cells causes a fatal lymphoproliferative disorder by impairing metabolic and functional processes, despite normal development and in vitro suppression.

bioRxiv · Jan 8, 2024Immunology

Clinical Efficacy of Prebiotics and Glycosaminoglycans versus Placebo In Dogs with Food Responsive Enteropathy Receiving a Hydrolyzed Diet: A Pilot Study

K. Allenspach, B. Glanemann, Y.-J. Seo, S. L. Priestnall, O. A. Garden, L. Kilburn, M. Rossoni-Serao, S. Segarra, J. P. Mochel

This pilot study evaluates if prebiotics and glycosaminoglycans reduce relapse in dogs with food-responsive enteropathy on a hydrolyzed diet, finding no significant difference compared to placebo.

bioRxiv · Apr 13, 2021Immunology